Related Experiment Videos
[Psychiatric complications of interferon therapy]
E Matsushita1, M Unoura, K Kobayashi
1First Department of Internal Medicine, Kanazawa University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 1, 1994
Summary
Interferon (IFN) therapy for chronic hepatitis C may cause subclinical psychiatric changes, particularly with IFN-alpha. Monitoring for these side effects is crucial, especially during IFN-alpha treatment.
Area of Science:
- Hepatology
- Psychiatry
- Pharmacology
Background:
- Chronic hepatitis C is a significant global health concern.
- Interferon (IFN) therapy is a common treatment for chronic hepatitis C.
- Psychiatric side effects of IFN therapy require careful evaluation.
Purpose of the Study:
- To investigate the psychiatric side effects of interferon therapy in patients with chronic hepatitis C.
- To compare the psychiatric impact of IFN-alpha and IFN-beta treatments.
Main Methods:
- A study involving 48 patients with chronic hepatitis C.
- Utilized the Cornell Medical Index (CMI) and Self-Depression Scale (SDS) for assessment.
- Compared outcomes between patients receiving IFN-alpha and IFN-beta.
Main Results:
- No overt psychiatric diseases were observed during IFN treatment.
- A statistically significant increase in Self-Depression Scale scores was noted in patients treated with IFN-alpha (p < 0.001).
- Patients treated with IFN-beta showed no significant increase in SDS scores.
Conclusions:
- Interferon therapy, especially IFN-alpha, may induce subclinical psychiatric abnormalities in chronic hepatitis C patients.
- Close attention to potential psychiatric side effects is warranted during interferon treatment.
- Further research is necessary to fully understand and manage these psychiatric effects.